These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2402311)

  • 1. EPO--one year later: a look at rehabilitation. A patient perspective--from patients.
    Harper G
    Nephrol News Issues; 1990 Jun; 4(6):40, 46. PubMed ID: 2402311
    [No Abstract]   [Full Text] [Related]  

  • 2. EPO--one year later: a look at rehabilitation. Does EPO impact on rehabilitation of the dialysis patient? A nursing perspective.
    Stevenson K; Binkley LS
    Nephrol News Issues; 1990 Jun; 4(6):30-1. PubMed ID: 2402309
    [No Abstract]   [Full Text] [Related]  

  • 3. EPO--one year later: a look at rehabilitation. Patient attitude key in impacting the job rate.
    Antonoff A
    Nephrol News Issues; 1990 Jun; 4(6):33-4, 48. PubMed ID: 2402310
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
    Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-transfusional anti-HLA hyperimmunization: importance of erythropoietin].
    Mourad G; Chong G; Cristol JP; Lorho R; Ramounau-Pigot A; Seignalet J
    Nephrologie; 1993; 14(2):91-4. PubMed ID: 8327032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin: mechanisms of action and indications for treatment.
    Vreugdenhil G; Frenken LA; Koene RA
    Neth J Med; 1993 Jun; 42(5-6):187-202. PubMed ID: 8377877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin and chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Zingraff J; Delons S; Kreis H; Varet B
    Nouv Rev Fr Hematol (1978); 1989; 31(2):97-8. PubMed ID: 2771635
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
    Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
    Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.
    Hamamori Y; Samal B; Tian J; Kedes L
    J Clin Invest; 1995 Apr; 95(4):1808-13. PubMed ID: 7706487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.
    Churchill DN; Muirhead N; Goldstein M; Posen G; Fay W; Beecroft ML; Gorman J; Taylor DW
    Clin Nephrol; 1995 Mar; 43(3):184-8. PubMed ID: 7774076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic occult intra-alveolar hemorrhage: a rare cause of failure to respond to erythropoietin.
    Conlon PJ; O'Neill S; O'Neill G; Kelly F; Donohoe J
    Clin Nephrol; 1994 Feb; 41(2):83-5. PubMed ID: 8004833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin, an update, and where to in the future?
    Sulková S
    EDTNA ERCA J; 1998; 24(3):30-2, 35. PubMed ID: 10392076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improvement of sexual function in hemodialyzed male patients with chronic renal failure treated with erythropoietin (rHuEPO)].
    Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
    Przegl Lek; 1995; 52(9):462-6. PubMed ID: 8834648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of recombinant erythropoietin in predialysis renal failure.
    Briggs WA; Gimenez LF
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):927-32. PubMed ID: 7852215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years].
    Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P
    Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.